CROSBY Research – Natural Food International (1837 HK/BUY): Better than expected FY23 results
27 Mar 2024 NFI’s FY23 topline was up by...
CROSBY Research – Q-Tech (1478 HK/BUY): Revenue growth turned around and GPM bottomed out in 2H23; expect product mix improvement persist into FY24
27 Mar 2024 After three consecutive decl...
CROSBY Research – WL Delicious (9985 HK): Expects a >15% YoY sales growth in FY24
25 Mar 2024 WL Delicious ‘s FY23 revenue...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 55)
25 Mar 2024 According to Reuters, China...
CROSBY Research – Sunny Optical (2382 HK/BUY): Conservative HLS/ HCM shipment and GPM guidance, but product mix improvement may be upside surprise
25 Mar 2024 After four consecutive decli...
CROSBY Research – Tai Hing (6811 HK): Turnaround in FY23 with a generous payout ratio
25 Mar 2024 Tai Hing’s FY23 revenue incr...
CROSBY Research – Vincent Medical (1612 HK/BUY): Achieving financial turnaround in FY23
21 Mar 2024 Vincent Medical’s FY23 turno...
CROSBY Research – Xiaomi Corporation (1810 HK): Solid 4Q23 core business recovery; launching of new EV will be near-term catalyst
21 Mar 2024 Xiaomi reported 4Q23 results...
CROSBY Research – Xtep International (1368 HK/BUY): Inline FY23 results ; Saucony achieved profitability
19 Mar 2024 Xtep’s FY23 revenue was up b...
CROSBY Research – China Lilang (1234 HK): Expects at least 15% retail sales growth in FY24
19 Mar 2024 The company reported a 14.8%...
CROSBY Research – Wasion Holdings (3393 HK/BUY): Strong FY23 NP growth on solid revenue growth and GPM improvement
18 Mar 2024 Following the positive profi...
CROSBY Research – Giordano (709 HK): FY23 NP rose by 29% YoY on higher GPM and operating leverage
18 Mar 2024 FY23 revenue slightly increa...
CROSBY Research – 361 Degrees (1361 HK/BUY): Solid FY23 results with strong growth from Kids and online segments
14 Mar 2024 FY23 revenue was up 21.0% Yo...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 54)
11 Mar 2024 (Bloomberg) Hong Kong’s 10 b...
CROSBY Research – Concord (182 HK/BUY): Solid FY23 results
08 Mar 2024 CNE’s FY23 revenue was up by...
CROSBY Research – JNBY (3306 HK): Net profit increased by 55% YoY on better margins
01 Mar 2024 JNBY announced its FY1H24 in...
CROSBY Research – Pentamaster International (1665 HK/BUY): Steady 4Q23 revenue growth and GPM expansion; medical devices segment remains key growth driver in FY24
01 Mar 2024 Pentamaster’s 4Q23 revenue i...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 53)
26 Feb 2024 2023 the global economic act...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 52)
06 Feb 2024 Under a so-called “whi...
CROSBY Research – Vincent Medical (1612 HK/BUY): Turnaround in FY23
02 Feb 2024 Vincent Medical (VM) issued...